New trends and price guide for the launch of obeticholic acid in 2024

Obeticholic Acid (OCA for short) is an innovative farnesolX receptor agonist and belongs to the bile acid class of drugs. This drug was successfully developed by the American pharmaceutical company Intercept and is the first drug specifically used to treat cholestatic liver disease in the past two decades. Obeticholic acid indirectly inhibits the gene expression of cytochrome 7A1 (CYP7A1) by activating the farnesol It is mainly used to treat primary biliary cholangitis (PBC), especially in patients with poor response to or intolerance to ursodeoxycholic acid (UDCA). Currently, many patients are very concerned about the domestic launch status and price information of this drug. This article will introduce it in detail.

1. New trends in listing

As of now, obeticholic acid has not been approved for marketing in China, and patients still need to purchase it through overseas channels. The original version of the drug is expensive, placing a financial burden on some patients. However, as the generic drug market continues to open up, patients now have more choices. Generic obeticholic acid drugs produced and sold by companies such as IndiaMylan, Laos ASEAN Pharmaceuticals, and Bangladesh Beacon Pharmaceuticals have gradually entered the Chinese market, providing patients with more purchasing channels. Patients can choose based on their needs and financial situation.

2. Price Information Guide

1. Original version: It is understood that a box of obeticholic acid original drug sells for thousands or even tens of thousands of yuan, which is a considerable expense for many patients.

2. IndiaMylan version: As a world-renowned major producer of generic drugs, India produces generic obeticholic acid drugs at relatively affordable prices. The version with specifications of 10mg*100 tablets is priced at more than 900 yuan per box. It is cost-effective and has become the first choice of many patients.

3. Laos ASEAN version: The obeticholic acid generic drug produced by Lao ASEAN Pharmaceuticals has the specification of 5mg*30 tablets. Each box is priced at about 600 yuan, providing another economical option for patients.

4. Bangladesh Beacon version: Bangladesh Beacon Pharmaceutical’s obeticholic acid generics also occupy a certain share in the market. Its specification is 5mg*30 tablets. Although the price per box is slightly higher than the Laos-ASEAN version, about more than 1,000 yuan, considering its brand reputation and drug quality, it is still favored by many patients.

It should be noted that the above price information is for reference only and may change due to factors such as channels and exchange rate fluctuations during actual purchase. In addition, patients should choose formal channels when purchasing to ensure the authenticity and effectiveness of drugs.

In summary, obeticholic acid is currently sold in multiple versions, providing more options for patients who require treatment with this drug. However, patients still need to exercise caution when purchasing to ensure that the medicine is safe and effective.